Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy

Cancer Science

Volumn 100, Issue 11, 2009, Pages 2188-2192

  Ogawa, Kazuma ^a   Shiba, Kazuhiro ^a   Akhter, Nasima ^a   Yoshimoto, Mitsuyoshi ^a   Washiyama, Kohshin ^a   Kinuya, Seigo ^a   Kawai, Keiichi ^b   Mori, Hirofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 2 [4 (4 IODOPHENYL)PIPERIDINO] CYCLOHEXANOL; HALOPERIDOL; RADIOACTIVE IODINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; VESAMICOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MUSCLE LEVEL; DRUG PURIFICATION; DRUG TUMOR LEVEL; DRUG UPTAKE; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGING SYSTEM; KIDNEY PARENCHYMA; LIVER PARENCHYMA; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIOACTIVITY; RADIOCHEMISTRY; RADIOISOTOPE THERAPY; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PIPERIDINES; RADIOPHARMACEUTICALS; RECEPTORS, SIGMA; TISSUE DISTRIBUTION;

EID: 71049136859     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01279.x     Document Type: Article

References (28)

1. Quirion R, Bowen WD, Itzhak Y. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992, 13:85-6.
2. Hanner M, Moebius FF, Flandorfer A. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 1996, 93:8072-7.
3. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 1996, 229:553-8.
4. Su TP. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit Rev Neurobiol 1993, 7:187-203.
5. Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995, 55:408-13.
6. Bem WT, Thomas GE, Mamone JY. Overexpression of sigma receptors in nonneural human tumors. Cancer Res 1991, 51:6558-62.
7. Mach RH, Smith CR, al-Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 1997, 57:156-61.
8. Wheeler KT, Wang LM, Wallen CA. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000, 82:1223-32.
9. Hirata M, Mori T, Umeda T, Abe T, Yamamoto T, Ohmomo Y. Evaluation of radioiodinated 1-[2-(3,4-Dimethoxyphenyl) ethyl]-4-(2-iodophenylpropyl) piperazine as a tumor diagnostic agent with functional sigma receptor imaging by single photon emission computed tomography. Biol Pharm Bull 2008, 31:879-83.
10. van Waarde A, Shiba K, de Jong JR, Ishiwata K, Dierckx RA, Elsinga PH. Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin. J Nucl Med 2007, 48:1320-6.
11. Shiba K, Yano T, Sato W, Mori H, Tonami N. Characterization of radioiodinated (-)-ortho-iodovesamicol binding in rat brain preparations. Life Sci 2002, 71:1591-8.
12. Shiba K, Ogawa K, Mori H. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand. Bioorg Med Chem 2005, 13:1095-9.
13. John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. Cancer Res 1999, 59:4578-83.
14. Shiba K, Mori H, Matsuda H. Synthesis of radioiodinated analogs of 2-(4-phenylpiperidino) cyclohexanol (vesamicol) as vesamicol-like agent. Nucl Med Biol 1995, 22:205-10.
15. Rogers GA, Parsons SM, Anderson DC. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino) cyclohexanol (vesamicol). J Med Chem 1989, 32:1217-30.
16. Akhter N, Shiba K, Ogawa K. A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging. Nucl Med Biol 2008, 35:29-34.
17. Shiba K, Ogawa K, Ishiwata K, Yajima K, Mori H. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor. Bioorg Med Chem 2006, 14:2620-6.
18. Wilson AA, Jin L, Garcia A, DaSilva JN, Houle S. An admonition when measuring the lipophilicity of radiotracers using counting techniques. Appl Radiat Isot 2001, 54:203-8.
19. Ogawa K, Mukai T, Arano Y. Rhenium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation. Nucl Med Biol 2006, 33:513-20.
20. Aydar E, Onganer P, Perrett R, Djamgoz MB, Palmer CP. The expression and functional characterization of sigma 1 receptors in breast cancer cell lines. Cancer Lett 2006, 242:245-57.
21. Tu Z, Dence CS, Ponde DE. Carbon-11 labeled sigma 2 receptor ligands for imaging breast cancer. Nucl Med Biol 2005, 32:423-30.
22. Hashimoto K, Ishiwata K. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 2006, 12:3857-76.
23. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 1994, 268:9-18.
24. Mach RH, Huang Y, Buchheimer N. [18F]N-4′-fluorobenzyl-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [18F]FDG, and [125I]IUDR. Nucl Med Biol 2001, 28:451-8.
25. Garg S, Kothari K, Thopate SR, Doke AK, Garg PK. Bioconjug Chem. 2009
26. Brandau W, Niehoff T, Pulawski P. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma. J Nucl Med 1996, 37:1865-71.
27. Kawamura K, Kubota K, Kobayashi T. Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET. Ann Nucl Med 2005, 19:701-9.
28. Waterhouse RN, Collier TL. In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl) piperidine: a selective sigma-1 receptor radioligand for PET. Nucl Med Biol 1997, 24:127-34.